DK4392560T3 - Konstruktioner og fremgangsmåder til fremstilling af cirkulært rna - Google Patents
Konstruktioner og fremgangsmåder til fremstilling af cirkulært rnaInfo
- Publication number
- DK4392560T3 DK4392560T3 DK22859855.3T DK22859855T DK4392560T3 DK 4392560 T3 DK4392560 T3 DK 4392560T3 DK 22859855 T DK22859855 T DK 22859855T DK 4392560 T3 DK4392560 T3 DK 4392560T3
- Authority
- DK
- Denmark
- Prior art keywords
- constructs
- methods
- circular rna
- producing circular
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y605/00—Ligases forming phosphoric ester bonds (6.5)
- C12Y605/01—Ligases forming phosphoric ester bonds (6.5) forming phosphoric ester bonds (6.5.1)
- C12Y605/01003—RNA ligase (ATP) (6.5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32341—Use of virus, viral particle or viral elements as a vector
- C12N2770/32343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021115029 | 2021-08-27 | ||
| PCT/CN2022/082225 WO2023024500A1 (en) | 2021-08-27 | 2022-03-22 | Constructs and methods for preparing circular rna |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4392560T3 true DK4392560T3 (da) | 2026-04-07 |
Family
ID=85321510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK22859855.3T DK4392560T3 (da) | 2021-08-27 | 2022-03-22 | Konstruktioner og fremgangsmåder til fremstilling af cirkulært rna |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240247265A1 (da) |
| EP (1) | EP4392560B1 (da) |
| JP (1) | JP7776176B2 (da) |
| KR (1) | KR20240046780A (da) |
| CN (1) | CN117795073A (da) |
| AU (1) | AU2022332372B2 (da) |
| CA (1) | CA3229816A1 (da) |
| DK (1) | DK4392560T3 (da) |
| FI (1) | FI4392560T3 (da) |
| MX (1) | MX2024001902A (da) |
| WO (1) | WO2023024500A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024151583A2 (en) | 2023-01-09 | 2024-07-18 | Flagship Pioneering Innovations Vii, Llc | Vaccines and related methods |
| WO2024167885A1 (en) | 2023-02-06 | 2024-08-15 | Flagship Pioneering Innovations Vii, Llc | Immunomodulatory compositions and related methods |
| WO2024254546A2 (en) * | 2023-06-08 | 2024-12-12 | Cornell University | Virus-like particles comprising circular mrna expression systems and methods of use thereof |
| GB202308675D0 (en) * | 2023-06-09 | 2023-07-26 | Res & Innovation Uk | Circular rnas and methods for making the same |
| CN119265241A (zh) | 2023-06-30 | 2025-01-07 | 深圳菁童生命科学有限公司 | 一种无相分离转录因子介导启始阶段重编程使细胞年轻化的方法 |
| WO2025072615A1 (en) * | 2023-09-29 | 2025-04-03 | Orbital Therapeutics, Inc. | Improved methods of making rna by splinted ligation and compositions thereof |
| KR102818452B1 (ko) * | 2023-12-18 | 2025-06-16 | 주식회사 뉴클릭스바이오 | Rna 라이게이즈를 이용한 신규 원형 rna 합성법 |
| TW202545974A (zh) | 2024-01-26 | 2025-12-01 | 美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 | 免疫受體抑制蛋白及相關方法 |
| US20250353881A1 (en) | 2024-05-16 | 2025-11-20 | Flagship Pioneering Innovations Vii, Llc | Immunoreceptor inhibitory proteins and related methods |
| WO2025245111A1 (en) | 2024-05-22 | 2025-11-27 | Flagship Pioneering Innovations Vii, Llc | Immunoreceptor targeting proteins and related methods |
| WO2026017174A1 (en) * | 2024-07-19 | 2026-01-22 | Ribox Therapeutics Hk Limited | Precursor rna molecules and methods for producing circular rnas |
| CN119040364B (zh) * | 2024-08-29 | 2025-06-27 | 优环(苏州)生物医药科技有限公司 | 一种基于核酶自剪接的无残留序列环状rna及其制备方法 |
| GB2644434A (en) * | 2024-08-30 | 2026-04-15 | Nunabio Ltd | Junction Regions, Templates and Methods for Nucleic Acid Synthesis |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5766903A (en) * | 1995-08-23 | 1998-06-16 | University Technology Corporation | Circular RNA and uses thereof |
| KR100992646B1 (ko) | 2003-07-09 | 2010-11-05 | 제이에스알 가부시끼가이샤 | 파장판 |
| US8603457B2 (en) | 2005-12-02 | 2013-12-10 | University Of Rochester | Nonsense suppression and genetic codon alteration by targeted modification |
| US8399007B2 (en) | 2006-12-05 | 2013-03-19 | Landec Corporation | Method for formulating a controlled-release pharmaceutical formulation |
| JP5296328B2 (ja) * | 2007-05-09 | 2013-09-25 | 独立行政法人理化学研究所 | １本鎖環状ｒｎａおよびその製造方法 |
| US20120027813A1 (en) | 2008-02-22 | 2012-02-02 | Novartis Vaccines And Diagnostics Srl | Adjuvanted influenza vaccines for pediatric use |
| US8506966B2 (en) | 2008-02-22 | 2013-08-13 | Novartis Ag | Adjuvanted influenza vaccines for pediatric use |
| BRPI1012036A2 (pt) | 2009-05-27 | 2017-10-10 | Selecta Biosciences Inc | nanocarreadores que possuem componentes com diferentes taxas de liberação |
| CA2798739A1 (en) | 2010-05-26 | 2011-12-01 | Selecta Biosciences, Inc. | Nanocarrier compositions with uncoupled adjuvant |
| RU2013154295A (ru) | 2011-06-08 | 2015-07-20 | Шир Хьюман Дженетик Терапис, Инк. | КОМПОЗИЦИИ ЛИПИДНЫХ НАНОЧАСТИЦ И СПОСОБЫ ДЛЯ ДОСТАВКИ мРНК |
| US10407683B2 (en) * | 2014-07-16 | 2019-09-10 | Modernatx, Inc. | Circular polynucleotides |
| EP4219532A3 (en) * | 2015-06-05 | 2023-08-16 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for transient gene therapy with enhanced stability |
| WO2018237372A1 (en) * | 2017-06-23 | 2018-12-27 | Cornell University | RNA MOLECULES, METHODS FOR PRODUCING CIRCULAR RNA, AND METHODS OF TREATMENT |
| JP7385282B2 (ja) * | 2017-11-07 | 2023-11-22 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 環状ｒｎａ分子のための方法及び組成物 |
| US11920131B2 (en) * | 2018-03-30 | 2024-03-05 | Toray Industries, Inc. | Method of producing hairpin single-stranded RNA molecule |
| CN112399860B (zh) * | 2018-06-06 | 2024-08-16 | 麻省理工学院 | 用于在真核细胞中翻译的环状rna |
| BR112021023411A2 (pt) | 2019-05-22 | 2022-02-01 | Massachusetts Inst Technology | Composições e métodos de rna circular |
| EP3997229A4 (en) | 2019-07-12 | 2024-07-03 | Peking University | TARGETED RNA EDITING BY HARNESSING ENDOGENOUS ADAR USING MODIFIED RNA |
| CN111321143B (zh) * | 2020-02-16 | 2021-09-17 | 中国海洋大学 | 一种制备环状rna的方法 |
| CN111690058B (zh) | 2020-03-30 | 2021-02-05 | 三优生物医药(上海)有限公司 | 针对冠状病毒的具有中和活性的抗体及其用途 |
-
2022
- 2022-03-22 EP EP22859855.3A patent/EP4392560B1/en active Active
- 2022-03-22 JP JP2024513118A patent/JP7776176B2/ja active Active
- 2022-03-22 FI FIEP22859855.3T patent/FI4392560T3/fi active
- 2022-03-22 CA CA3229816A patent/CA3229816A1/en active Pending
- 2022-03-22 KR KR1020247009440A patent/KR20240046780A/ko active Pending
- 2022-03-22 WO PCT/CN2022/082225 patent/WO2023024500A1/en not_active Ceased
- 2022-03-22 MX MX2024001902A patent/MX2024001902A/es unknown
- 2022-03-22 DK DK22859855.3T patent/DK4392560T3/da active
- 2022-03-22 CN CN202280053158.8A patent/CN117795073A/zh active Pending
- 2022-03-22 AU AU2022332372A patent/AU2022332372B2/en active Active
-
2024
- 2024-02-26 US US18/587,710 patent/US20240247265A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024531486A (ja) | 2024-08-29 |
| KR20240046780A (ko) | 2024-04-09 |
| CA3229816A1 (en) | 2023-03-02 |
| FI4392560T3 (fi) | 2026-04-23 |
| AU2022332372B2 (en) | 2025-12-04 |
| AU2022332372A1 (en) | 2024-02-29 |
| EP4392560A1 (en) | 2024-07-03 |
| CN117795073A (zh) | 2024-03-29 |
| EP4392560B1 (en) | 2026-03-11 |
| WO2023024500A1 (en) | 2023-03-02 |
| US20240247265A1 (en) | 2024-07-25 |
| MX2024001902A (es) | 2024-05-16 |
| JP7776176B2 (ja) | 2025-11-26 |
| EP4392560A4 (en) | 2024-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK4392560T3 (da) | Konstruktioner og fremgangsmåder til fremstilling af cirkulært rna | |
| DK4516357T3 (da) | Antitumorforbindelse, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| EP3826643A4 (en) | Circularized engineered rna and methods | |
| DK3601358T5 (da) | Anti-trem2-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3460042T3 (da) | Celledyrkningsmedium til dyrkning af et organoid, dyrkningsfremgnagsmåde og organoid | |
| DK4075992T3 (da) | Isoleret oleosomsammensætning og fremgangsmåde til fremstilling heraf | |
| DK3491025T3 (da) | Fcrn-antistoffer og anvendelsesmetoder heraf | |
| DK3635009T3 (da) | Sammensætninger og fremgangsmåder til internalisering af enzymer | |
| DK3888789T3 (da) | Hydrocrackingkatalysator, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| DK3405602T3 (da) | Fremgangsmåde og indretning til elektrokemisk fremstilling af syntesegas | |
| DK3826667T3 (da) | Claudin6-antistoffer og fremgangsmåder til behandling af kræft | |
| DK2708602T3 (da) | Xylanaser, nukleinsyrer der koder for dem og fremgangsmåder til fremstilling og anvendelse af dem | |
| DK3280440T3 (da) | Humaniserede anti-c1s-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3577213T3 (da) | Mikrobielle celler, fremgangsmåder til frembringelse af disse og anvendelser deraf | |
| DK3768879T3 (da) | System og fremgangsmåde til frembringelse af gasser | |
| DK3074544T3 (da) | Martensitholdigt rustfrit stål, stykke udført i dette stål og fremgangsmåde til fremstilling heraf | |
| EP3976068A4 (en) | CYTOKINE COCKTAILS FOR SELECTIVE T-LYMPHOCYTE SUBSET EXPANSION | |
| DK2998388T3 (da) | Mikroorganisme, der producerer o-acetyl-homoserin, og fremgangsmåde til produktion af o-acetyl-homoserin ved hjælp af mikroorganisme | |
| DK3541947T3 (da) | Fremgangsmåde til fremstilling af elektrokompetente gærceller og fremgangsmåde til anvendelse af cellerne | |
| DK4212509T3 (da) | Fremgangsmåde til fremstilling af vandopløseligt magnolol-derivat og honokiol-derivat, fremgangsmåder til fremstilling af mellemprodukter af vandopløseligt magnolol-derivat og honokiol-derivat og relaterede monohydroxybeskyttede mellemprodukter | |
| DK3368578T3 (da) | Anti-HtrA1-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3642331T3 (da) | Fremgangsmåde til udvidelse af T-celler og anvendelser deraf | |
| IL304401A (en) | Blastocyst-like cell aggregate and methods | |
| DK3816434T3 (da) | Vindmølle og dertilhørende fremgangsmåde | |
| DK4202509T3 (da) | Bølgeledere og fremgangsmåder til fremstilling deraf |